Home Cart 0 Sign in  
X

[ CAS No. 34604-60-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 34604-60-9
Chemical Structure| 34604-60-9
Chemical Structure| 34604-60-9
Structure of 34604-60-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 34604-60-9 ]

Related Doc. of [ 34604-60-9 ]

Alternatived Products of [ 34604-60-9 ]

Product Details of [ 34604-60-9 ]

CAS No. :34604-60-9 MDL No. :MFCD11978170
Formula : C5H4N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :CGQFCIHUUCMACC-UHFFFAOYSA-N
M.W : 140.10 Pubchem ID :161825
Synonyms :

Calculated chemistry of [ 34604-60-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 31.82
TPSA : 83.05 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.85 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.19
Log Po/w (XLOGP3) : -0.98
Log Po/w (WLOGP) : -0.53
Log Po/w (MLOGP) : -1.36
Log Po/w (SILICOS-IT) : 0.47
Consensus Log Po/w : -0.44

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -0.47
Solubility : 47.6 mg/ml ; 0.339 mol/l
Class : Very soluble
Log S (Ali) : -0.28
Solubility : 73.8 mg/ml ; 0.527 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.91
Solubility : 17.4 mg/ml ; 0.124 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.71

Safety of [ 34604-60-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 34604-60-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 34604-60-9 ]
  • Downstream synthetic route of [ 34604-60-9 ]

[ 34604-60-9 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 34604-60-9 ]
  • [ 89323-09-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 2, p. 450 - 453
  • 2
  • [ 67-56-1 ]
  • [ 34604-60-9 ]
  • [ 13924-95-3 ]
YieldReaction ConditionsOperation in experiment
65%
Stage #1: at -20℃; for 0.5 h;
Stage #2: for 2 h; Reflux
Preparation 405-Hvdroxy-pyrazine-2-carboxylic acid methyl esterThionyl chloride (152ml_, 2.08mol) was added dropwise at -20 °C to methanol (5L). After the addition was completed, the mixture was stirred at this temperature for 30 minutes. Then 5- hydroxy-pyrazine-2-carboxylic acid (100g, 714mmol) was added, and the mixture was heated at reflux for 2 hours. The reaction mixture was concentrated in vacuo, and the residue was recrystallised from methanol (400ml_) to give 71 g (464mmol) of the title compound in 65percent yield.
61% With hydrogenchloride In 1,4-dioxane; water at 60 - 80℃; for 4 h; (62a)
Methyl 5-hydroxypyrazine-2-carboxylate
Commercially available 5-hydroxypyrazine-2-carboxylic acid (1.00 g, 7.14 mmol) was dissolved in methanol (5 mL), and a 4N hydrochloric acid/dioxane solution (25 mL) was added, followed by stirring at 60°C for 1.5 hours and heating to reflux at 80°C for 2.5 hours.
The reaction solution was brought back to room temperature, the solvent was distilled off under reduced pressure, and ethyl acetate (20 mL) was added to the resulting residue to allow it to be suspended.
The resulting precipitate was filtered off, and washed with ethyl acetate, followed by vacuum drying, to afford the desired compound (673 mg, yield 61percent) as an orange-brown solid.
1H-NMR (CD3OD, 400 MHz): δ 3.31 (1H, s), 3.85 (3H, s), 8.00 (1H, d, J=1.2 Hz), 8.13 (1H, d, J=1.2 Hz).
Reference: [1] Patent: WO2013/14567, 2013, A1, . Location in patent: Page/Page column 80-81
[2] Patent: EP2239253, 2010, A1, . Location in patent: Page/Page column 96
[3] Patent: EP1452525, 2004, A1, . Location in patent: Page 15
  • 3
  • [ 298-12-4 ]
  • [ 18514-52-8 ]
  • [ 34604-60-9 ]
Reference: [1] Patent: EP1452525, 2004, A1, . Location in patent: Page 15
  • 4
  • [ 36070-80-1 ]
  • [ 34604-60-9 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 407 - 408
  • 5
  • [ 82619-62-3 ]
  • [ 34604-60-9 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 407 - 408
  • 6
  • [ 82619-63-4 ]
  • [ 34604-60-9 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 407 - 408
  • 7
  • [ 34604-60-9 ]
  • [ 36070-80-1 ]
YieldReaction ConditionsOperation in experiment
93% With thionyl chloride In N,N-dimethyl-formamide at 80℃; for 16 h; Step 1: Preparation of 5-chloropyrazine-2-carboxylic acid [0170] To a solution 5-hydroxypyrazine-2-carboxylic acid (10 g, 71.42 mmol) in thionyl chloride (100 mL) was added N, N- dimethyl formamide (1 mL) and the reaction mixture was stirred at 80 °C for 16 h. Thionyl chloride was distilled off, the residue was diluted with ice water and extracted ethyl acetate (600 mL x 3). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated. The crude was triturated with diethyl ether to afford the title compound 5-chloropyrazine-2-carboxylic acid (10.53 g, 93percent yield) as a brown solid. Calculated M+H: 158.99; Found M+H: 159.0.
75% for 16 h; Reflux Intermediate 44; 5-Chloropyrazine-2-carboxylic acid; 5-Hydroxypyrazine-2-carboxylic acid (1.0 g, 0.007 mol) was taken in thionyl chloride (10 mL), to this solution dimethylformamide (0.1 mL) was added which was heated to reflux for 16 h. After this period, excess thionyl chloride was distilled off to get crude compound, which was added to ice (20 g) and extracted with ethyl acetate (2 x 70 mL). The organic layers were combined and dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain brown solid which was triturated with diethyl ether (30 mL) to afford 600 mg (75percent) of 5-chloropyrazine-2-carboxylic acid.1H NMR (400 MHz, DMSO-d): δ 8.94 (s, IH), 9.04 (s, IH), 13.92 (s, IH). Mass (APCI): m/z 157.0 (M-H).
Reference: [1] Patent: WO2015/48507, 2015, A1, . Location in patent: Paragraph 0170
[2] Patent: WO2010/67123, 2010, A1, . Location in patent: Page/Page column 183
[3] European Journal of Medicinal Chemistry, 2015, vol. 101, p. 692 - 704
  • 8
  • [ 34604-60-9 ]
  • [ 36070-80-1 ]
Reference: [1] Organic Process Research and Development, 2018, vol. 22, # 2, p. 241 - 246
  • 9
  • [ 34604-60-9 ]
  • [ 21279-64-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 2, p. 450 - 453
  • 10
  • [ 67-56-1 ]
  • [ 34604-60-9 ]
  • [ 33332-25-1 ]
Reference: [1] Patent: WO2012/40137, 2012, A1, . Location in patent: Page/Page column 90
[2] Patent: WO2012/40139, 2012, A1, . Location in patent: Page/Page column 83
  • 11
  • [ 67-56-1 ]
  • [ 34604-60-9 ]
  • [ 33332-25-1 ]
Reference: [1] Medicinal Chemistry Research, 2015, vol. 24, # 7, p. 2986 - 2992
  • 12
  • [ 34604-60-9 ]
  • [ 33332-25-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 10, p. 3057 - 3063
  • 13
  • [ 34604-60-9 ]
  • [ 33332-25-1 ]
Reference: [1] Patent: WO2013/14567, 2013, A1,
  • 14
  • [ 34604-60-9 ]
  • [ 40155-42-8 ]
Reference: [1] Patent: WO2015/48507, 2015, A1,
  • 15
  • [ 34604-60-9 ]
  • [ 160252-31-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 11, p. 3705 - 3720
  • 16
  • [ 34604-60-9 ]
  • [ 72788-94-4 ]
Reference: [1] Patent: WO2011/14774, 2011, A1, . Location in patent: Page/Page column 23
  • 17
  • [ 34604-60-9 ]
  • [ 1209646-17-2 ]
Reference: [1] Patent: WO2012/40139, 2012, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 34604-60-9 ]

Amides

Chemical Structure| 13924-99-7

[ 13924-99-7 ]

6-Oxo-1,6-dihydropyrazine-2-carboxylic acid

Similarity: 0.82

Chemical Structure| 69904-06-9

[ 69904-06-9 ]

6-Aminoquinoxalin-2(1H)-one

Similarity: 0.64

Chemical Structure| 89283-33-0

[ 89283-33-0 ]

3-Chloro-5-methylpyrazin-2(1H)-one

Similarity: 0.63

Chemical Structure| 6270-63-9

[ 6270-63-9 ]

Pyrazin-2(1H)-one

Similarity: 0.61

Chemical Structure| 140862-42-6

[ 140862-42-6 ]

3-Chloro-5,6-dimethylpyrazin-2(1H)-one

Similarity: 0.59

Carboxylic Acids

Chemical Structure| 13924-99-7

[ 13924-99-7 ]

6-Oxo-1,6-dihydropyrazine-2-carboxylic acid

Similarity: 0.82

Chemical Structure| 788819-82-9

[ 788819-82-9 ]

Imidazo[1,2-a]pyrazine-6-carboxylic acid

Similarity: 0.71

Chemical Structure| 1457-58-5

[ 1457-58-5 ]

2-Methyl-1H-imidazole-5-carboxylic acid

Similarity: 0.70

Chemical Structure| 77112-53-9

[ 77112-53-9 ]

Imidazo[1,2-a]pyrazine-2-carboxylic acid

Similarity: 0.70

Chemical Structure| 40155-43-9

[ 40155-43-9 ]

5-Aminopyrazine-2-carboxylic acid

Similarity: 0.65

Related Parent Nucleus of
[ 34604-60-9 ]

Pyrazines

Chemical Structure| 13924-99-7

[ 13924-99-7 ]

6-Oxo-1,6-dihydropyrazine-2-carboxylic acid

Similarity: 0.82

Chemical Structure| 40155-43-9

[ 40155-43-9 ]

5-Aminopyrazine-2-carboxylic acid

Similarity: 0.65

Chemical Structure| 89283-33-0

[ 89283-33-0 ]

3-Chloro-5-methylpyrazin-2(1H)-one

Similarity: 0.63

Chemical Structure| 13515-06-5

[ 13515-06-5 ]

5,6-Dimethylpyrazine-2-carboxylic acid

Similarity: 0.62

Chemical Structure| 41110-29-6

[ 41110-29-6 ]

Methyl 3-methylpyrazine-2-carboxylate

Similarity: 0.62